Deacetylase inhibitors CM-444 and CM-1758 enhance chemotherapy response in AML via ALOX5.
- DOI
- 10.1111/bjh.70520
- Published
- 2026 Jul
- Container
- British journal of haematology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/bjh.70520,
title = {Deacetylase inhibitors CM-444 and CM-1758 enhance chemotherapy response in AML via ALOX5.},
author = {Gimenez-Camino N and San José-Enériz E and Garate L and Miranda E and Sáez E and Pineda-Lucena A and Prósper F and Agirre X},
year = {2026},
journal = {British journal of haematology},
doi = {10.1111/bjh.70520},
url = {https://doi.org/10.1111/bjh.70520}
}RIS
TY - JOUR TI - Deacetylase inhibitors CM-444 and CM-1758 enhance chemotherapy response in AML via ALOX5. AU - Gimenez-Camino N AU - San José-Enériz E AU - Garate L AU - Miranda E AU - Sáez E AU - Pineda-Lucena A AU - Prósper F AU - Agirre X PY - 2026 JO - British journal of haematology DO - 10.1111/bjh.70520 UR - https://doi.org/10.1111/bjh.70520 ER -
APA
N, G., E, S. J., L, G., E, M., E, S., A, P., F, P., & X, A. (2026). Deacetylase inhibitors CM-444 and CM-1758 enhance chemotherapy response in AML via ALOX5.. British journal of haematology. https://doi.org/10.1111/bjh.70520
Source records
- pubmed · retrieved 2026-09-26T03:38:58.996Z